MergerLoop
  • Home
  • All Deals
  • Newsletter
  • 20 Weeks In Report
Back to register

MergerLoop is a DDLoop project

Back to register
WA-25014

CVC Capital Partners / The animal nutrition and health division of the DSM-Firmenich GroupWA-25014

View on ACCC

Processing timeline

17

days

Filed

21 Mar 2026

Notification waiver determination published

Decision

7 Apr 2026Notification waiver determination published
Type
Waiver
Outcome
Approved
Stage
Waiver application
Status
Assessment completed

Parties

Acquirer(s)

Essential Bidco B.V., Specialty (U.S.) Bidco, Inc., Essential (U.S.) Bidco, Inc., Specialty Bidco B.V.

Target(s) or Vendor(s)

SpecialtyCo US LLC, Biomin Phytogenics GmbH (Germany), DSM Nutritional Products Holding AG (Switzerland), EssentialCo Holding AG, Animal Nutrition & Health, LLC (US), DSM Nutritional Products GmbH, DSM Nutritional Products Vietnam Ltd (Vietnam), DSM B.V. Dutch Commercial Register 14022069

Other parties

CVC Capital Partners, DSM-Firmenich AG

Summary

CVC Capital Partners, via newly formed entities, acquired the Animal Nutrition & Health business from DSM-Firmenich AG. This private equity investment targets a global provider of science-based animal nutrition and health solutions for livestock producers and feed manufacturers, including vitamins and premixes.

Acquisition details

The Acquisition is a private equity financial investment concerning the acquisition of DSM-Firmenich AG’s Animal Nutrition & Health business (the Target ) by the following newly formed companies: Specialty Bidco B.V.; Specialty (U.S.) Bidco, Inc.; Essential Bidco B.V.; and Essential (U.S.) Bidco, Inc. These companies are all indirectly controlled by funds advised or managed by affiliates of CVC Capital Partners plc ( CVC Capital Partners ), a public limited company incorporated in Jersey and listed in Amsterdam. The CVC Network is a global alternative investment manager focused on private equity, credit, infrastructure and secondaries, and includes CVC Capital Partners, each of its subsidiaries, and the CVC Funds. The seller is DSM B.V., a private limited liability company incorporated in the Netherlands and part of DSM-Firmenich AG. The Target is a global provider of science-based animal nutrition and health solutions for livestock producers and feed manufacturers. Its global activities span: vitamins and carotenoids; premixes; performance solutions; aroma ingredients; and precision services.

Industry

Broad:Industrial ManufacturingANZSIC 1199:Other Food Product Manufacturing n.e.c.ANZSIC 6240:Financial Asset Investing

Decisions and key events

7 Apr 2026Notification waiver determination publishedAttachmentPDF154.5 KB

More Industrial Manufacturing deals

  • CVC Capital Partners / Marathon Asset ManagementMN-65009 · Notification · Approved
  • CVC Capital Partners / Smiths Detection GroupWA-40003 · Waiver · Approved
  • EBOS / Paringa Pet FoodsMN-30020 · Notification · Filed 11 June 2026
  • Equans / CV Services GroupMN-05025 · Notification · Filed 9 June 2026
  • Henkel / OlaplexMN-80016 · Notification · Filed 26 May 2026
  • Platinum Equity Group / LMPGWA-80020 · Waiver · Approved